Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0282473 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Jonathan A R Gordon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The tumor microenvironment is a complex mixture of cell types that bi-directionally interact and influence tumor initiation, progression, recurrence, and patient survival. Mesenchymal stromal cells (MSCs) of the tumor microenvironment engage in crosstalk with cancer cells to mediate epigenetic control of gene expression. We identified CD90+ MSCs residing in the tumor microenvironment of patients with invasive breast cancer that exhibit a unique gene expression signature. Single-cell transcriptional analysis of these MSCs in tumor-associated stroma identified a distinct subpopulation characterized by increased expression of genes functionally related to extracellular matrix signaling. Blocking the TGFβ pathway reveals that these cells directly contribute to cancer cell proliferation. Our findings provide novel insight into communication between breast cancer cells and MSCs that are consistent with an epithelial to mesenchymal transition and acquisition of competency for compromised control of proliferation, mobility, motility, and phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biochemistry, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
- Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
- Department of Surgery, Larner College of Medicine at the University of Vermont, Burlington, VT, United States of America.
ORCID-Profile: Janet L Stein
Förderung
- NIDCR NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Cancer Institute
- American Cancer Society
Zitieren
APA
Gordon, J. A. R., Evans, M. F., Ghule, P. N., Lee, K., Vacek, P., Sprague, B. L., Weaver, D. L., Stein, G. S., & Stein, J. L. (2023). Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0282473
Vancouver
Gordon JAR, Evans MF, Ghule PN, Lee K, Vacek P, Sprague BL, et al. Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients. PLOS ONE. 2023. doi:10.1371/journal.pone.0282473
BibTeX
@article{Gordon2023,
author = {Gordon, Jonathan A R and Evans, Mark F and Ghule, Prachi N and Lee, Kyra and Vacek, Pamela and Sprague, Brian L and Weaver, Donald L and Stein, Gary S and Stein, Janet L},
title = {Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0282473}
}
EUVIMED